OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
3143$690.0057

O' will Corp

Food Retail & DistributionVerified

O'Will Corp maintains a debt-to-equity ratio of 0.93, indicating a moderate reliance on debt financing, while its current ratio of 1.86 suggests sufficient short-term liquidity to cover obligations. The company's liquidity position is further supported by cash and equivalents of ¥2.86 billion, though this is offset by long-term debt of ¥4.76 billion, resulting in a net cash position that is negative after subtracting total debt. Profitability metrics show a return on equity (ROE) of 17.86% and a return on assets (ROA) of 5.64%, both exceeding the typical thresholds for the Food Retail & Distribution industry, which is characterized by thin margins and high operational efficiency. The company's operating margin of 3.41% (calculated from operating income of ¥1.33 billion on revenue of ¥39.16 billion) is in line with industry norms, but its net margin of 2.34% (net income of ¥915.10 million) suggests some pressure from operating expenses or interest costs. Geographically, O'Will Corp's revenue is concentrated in Japan, with no disclosed international operations. The company's segmental breakdown is not provided in the input data, but its business model is likely centered on domestic retail and distribution of food and drug products. This concentration may expose the company to domestic economic and regulatory risks, though the input data does not provide specific details on regional revenue distribution. Looking ahead, the company's revenue is projected to grow by 2.1% in the current fiscal year and 1.8% in the next, based on analyst estimates and historical performance. These growth rates are modest but in line with the industry's conservative expansion trends. The company's capital expenditure of ¥47.6 million in the latest period suggests a focus on maintaining rather than expanding physical infrastructure. Risk factors include a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued new shares recently and has a low probability of near-term dilution. The company's free cash flow of ¥813.42 million provides some flexibility for debt reduction or shareholder returns, though the negative operating cash flow of ¥829.43 million indicates potential challenges in cash generation from core operations. Recent events include the filing of the latest financial results, which show a revenue of ¥39.16 billion and an EPS of ¥305.73, aligning with analyst estimates. No significant regulatory or operational events are disclosed in the input data, suggesting a stable but unremarkable near-term outlook.

30-day price · 3143-48.00 (-6.8%)
Low$655.00High$767.00Close$662.00As of21 May, 00:00 UTC
Profile
CompanyO' will Corp
Ticker3143.T
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. O'Will Corp operates in the Food & Drug Retailing industry, generating revenue primarily through the retail and distribution of food and drug products.

Classification. O'Will Corp is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry with a confidence level of 0.92.

O'Will Corp maintains a debt-to-equity ratio of 0.93, indicating a moderate reliance on debt financing, while its current ratio of 1.86 suggests sufficient short-term liquidity to cover obligations. The company's liquidity position is further supported by cash and equivalents of ¥2.86 billion, though this is offset by long-term debt of ¥4.76 billion, resulting in a net cash position that is negative after subtracting total debt. Profitability metrics show a return on equity (ROE) of 17.86% and a return on assets (ROA) of 5.64%, both exceeding the typical thresholds for the Food Retail & Distribution industry, which is characterized by thin margins and high operational efficiency. The company's operating margin of 3.41% (calculated from operating income of ¥1.33 billion on revenue of ¥39.16 billion) is in line with industry norms, but its net margin of 2.34% (net income of ¥915.10 million) suggests some pressure from operating expenses or interest costs. Geographically, O'Will Corp's revenue is concentrated in Japan, with no disclosed international operations. The company's segmental breakdown is not provided in the input data, but its business model is likely centered on domestic retail and distribution of food and drug products. This concentration may expose the company to domestic economic and regulatory risks, though the input data does not provide specific details on regional revenue distribution. Looking ahead, the company's revenue is projected to grow by 2.1% in the current fiscal year and 1.8% in the next, based on analyst estimates and historical performance. These growth rates are modest but in line with the industry's conservative expansion trends. The company's capital expenditure of ¥47.6 million in the latest period suggests a focus on maintaining rather than expanding physical infrastructure. Risk factors include a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued new shares recently and has a low probability of near-term dilution. The company's free cash flow of ¥813.42 million provides some flexibility for debt reduction or shareholder returns, though the negative operating cash flow of ¥829.43 million indicates potential challenges in cash generation from core operations. Recent events include the filing of the latest financial results, which show a revenue of ¥39.16 billion and an EPS of ¥305.73, aligning with analyst estimates. No significant regulatory or operational events are disclosed in the input data, suggesting a stable but unremarkable near-term outlook.
Key takeaways
  • O'Will Corp maintains a moderate debt load and sufficient short-term liquidity to cover obligations.
  • The company's profitability metrics, particularly ROE and ROA, are strong relative to industry norms.
  • Revenue is concentrated in Japan, with no disclosed international operations.
  • Growth projections are modest but in line with industry trends.
  • The company faces a medium liquidity risk and a low dilution risk.
  • Recent financial results align with analyst estimates, indicating stable performance.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$39.16B
Gross profit$4.06B
Operating income$1.33B
Net income$915.1M
R&D
SG&A
D&A
SBC
Operating cash flow-$829.4M
CapEx-$47.6M
Free cash flow$813.4M
Total assets$16.23B
Total liabilities$11.11B
Total equity$5.12B
Cash & equivalents$2.86B
Long-term debt$4.76B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$41.91B$1.28B$793.9M$685.1M
FY-1$39.16B$1.33B$915.1M$813.4M
FY-2$31.78B$958.8M$681.5M$399.2M
FY-3$31.26B$942.4M$580.5M$463.1M
FY-4$28.31B$832.6M$575.5M$464.6M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$20.48B$5.92B$2.54B
FY-1$16.23B$5.12B$2.86B
FY-2$13.63B$4.40B$1.85B
FY-3$11.45B$4.05B$1.79B
FY-4$10.52B$3.68B$1.78B
PeriodOCFCapExFCFSBC
FY0-$1.02B-$51.4M$685.1M
FY-1-$829.4M-$47.6M$813.4M
FY-2$280.5M-$214.8M$399.2M
FY-3$184.9M-$40.6M$463.1M
FY-4$149.5M-$23.5M$464.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$9.56B-$125.7M-$57.7M
FQ-1$10.74B$376.5M$220.8M
FQ-2$10.91B$433.5M$247.1M
FQ-3$10.69B$597.4M$383.7M
FQ-4$8.70B$216.9M$165.6M
FQ-5$9.91B$322.9M$199.5M
FQ-6$11.16B$413.2M$317.5M
FQ-7$9.39B$381.4M$232.5M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$20.48B$5.92B$2.54B
FQ-1$22.00B$5.92B$3.54B
FQ-2$18.96B$5.68B$2.66B
FQ-3$17.95B$5.39B$2.27B
FQ-4$16.23B$5.12B$2.86B
FQ-5$18.48B$5.05B$3.23B
FQ-6$16.74B$4.71B$3.09B
FQ-7$18.48B$4.53B$3.04B
PeriodOCFCapExFCFSBC
FQ0-$1.02B-$51.4M
FQ-1
FQ-2$936.6M-$13.1M
FQ-3
FQ-4-$829.4M-$47.6M
FQ-5
FQ-6-$347.1M-$20.6M
FQ-7
Valuation
Market price$690.00
Market cap$6.22B
Enterprise value$8.12B
P/E6.8
Reported non-GAAP P/E
EV/Revenue0.2
EV/Op income6.1
EV/OCF
P/B1.2
P/Tangible book1.2
Tangible book$5.12B
Net cash-$1.90B
Current ratio1.9
Debt/Equity0.9
ROA5.6%
ROE17.9%
Cash conversion-91.0%
CapEx/Revenue-0.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
Metric3143Activity
Op margin3.4%2.8% medp25 0.9% · p75 5.9%above median
Net margin2.3%1.8% medp25 0.3% · p75 3.6%above median
Gross margin10.4%24.1% medp25 13.8% · p75 31.4%bottom quartile
CapEx / revenue-0.1%-2.0% medp25 -3.8% · p75 -1.0%top quartile
Debt / equity93.0%56.0% medp25 14.0% · p75 113.8%above median
Observations
IR observations
Last actual EPS305.73 JPY
Last actual revenue39,156,010,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:37 UTC#7a77ae41
Market quoteclose JPY 690.00 · shares 0.01B diluted
no public URL
2026-05-12 00:37 UTC#89c38b13
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 00:39 UTCJob: 2bc0f5d3